United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market (2025-2031) | Value, Outlook, Trends, Industry, Share, Growth, Size & Revenue, Competitive Landscape, Segmentation, Forecast, Analysis, Companies

Market Forecast By Indication (Multiple sclerosis, Alzheimers Disease, Parkinsons Disease, Huntingtons Disease, Others), By Drug Glass (Immunomodulator, Interferons, Decarboxylase Inhibitors, Dopamine Agonists, Others), By Route of Administration (Oral, Injection, Transdermal), By End- User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) And Competitive Landscape
Product Code: ETC9949727 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Outlook
  • Market Size of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market, 2024
  • Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market, 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Revenues & Volume for the Period 2021- 2031
  • United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Trend Evolution
  • United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Drivers and Challenges
  • United Kingdom (UK) Neurodegenerative Disorder Therapeutics Price Trends
  • United Kingdom (UK) Neurodegenerative Disorder Therapeutics Porter's Five Forces
  • United Kingdom (UK) Neurodegenerative Disorder Therapeutics Industry Life Cycle
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Indication for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Multiple sclerosis for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Alzheimers Disease for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Parkinsons Disease for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Huntingtons Disease for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Drug Glass for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Immunomodulator for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Interferons for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Decarboxylase Inhibitors for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Dopamine Agonists for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Oral for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Injection for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Transdermal for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By End- User for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Retail Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume By Online Pharmacy for the Period 2021- 2031
  • United Kingdom (UK) Neurodegenerative Disorder Therapeutics Import Export Trade Statistics
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By Drug Glass
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By End- User
  • United Kingdom (UK) Neurodegenerative Disorder Therapeutics Top Companies Market Share
  • United Kingdom (UK) Neurodegenerative Disorder Therapeutics Competitive Benchmarking By Technical and Operational Parameters
  • United Kingdom (UK) Neurodegenerative Disorder Therapeutics Company Profiles
  • United Kingdom (UK) Neurodegenerative Disorder Therapeutics Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Overview

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market - Industry Life Cycle

3.4 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market - Porter's Five Forces

3.5 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.6 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume Share, By Drug Glass, 2021 & 2031F

3.7 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume Share, By End- User, 2021 & 2031F

4 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of neurodegenerative disorders in the UK

4.2.2 Technological advancements in the development of therapeutics

4.2.3 Growing awareness and focus on research in neurodegenerative disorders

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval

4.3.2 High cost associated with research and development of therapeutics

4.3.3 Limited availability of effective treatment options

5 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Trends

6 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market, By Types

6.1 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market, By Indication

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Indication, 2021- 2031F

6.1.3 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Multiple sclerosis, 2021- 2031F

6.1.4 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F

6.1.5 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F

6.1.6 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Huntingtons Disease, 2021- 2031F

6.1.7 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

6.2 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market, By Drug Glass

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Immunomodulator, 2021- 2031F

6.2.3 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Interferons, 2021- 2031F

6.2.4 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Decarboxylase Inhibitors, 2021- 2031F

6.2.5 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Dopamine Agonists, 2021- 2031F

6.2.6 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

6.3 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Injection, 2021- 2031F

6.3.4 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Transdermal, 2021- 2031F

6.4 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market, By End- User

6.4.1 Overview and Analysis

6.4.2 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.4.3 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.4.4 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

7 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Import-Export Trade Statistics

7.1 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Export to Major Countries

7.2 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Imports from Major Countries

8 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Key Performance Indicators

8.1 Patient enrollment in clinical trials for neurodegenerative disorder therapeutics

8.2 Number of research grants and funding allocated for neurodegenerative disorders

8.3 Adoption rate of innovative therapeutic approaches in the market

9 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market - Opportunity Assessment

9.1 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Opportunity Assessment, By Indication, 2021 & 2031F

9.2 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Opportunity Assessment, By Drug Glass, 2021 & 2031F

9.3 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Opportunity Assessment, By End- User, 2021 & 2031F

10 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market - Competitive Landscape

10.1 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Neurodegenerative Disorder Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All